S.Korea’s CDMO giant Samsung Biologics to offer CRO services
Samsung Biologics Co., the world’s largest contract drugmaker, will enter the contract research organization (CRO) market by leveraging its va...
Samsung Biologics to spin off biosimilar unit Samsung Bioepis
Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract development and manufac...
CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
CJ CheilJedang Corp., South Korea’s largest food and beverage company, said on Wednesday it has scrapped a planned sale of its green bio busin...
ABL Bio lands $2.8 billion license-out deal with GSK
ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called the Grabody-B, to UK-bas...
MBK Partners poised to acquire CJ Cheiljedang’s $3.5 billion bio business
North Asia-focused private equity firm MBK Partners is on the verge of clinching a major acquisition deal by offering a higher bid than other conten...
MBK Partners, 2 Chinese firms vie for CJ Cheiljedang’s $4 bn bio business
North Asia-focused private equity firm MBK Partners and two leading Chinese biotechnology firms are vying for management control of CJ Cheiljedang C...
Lotte Biologics eyes first ADC CDMO order in 2025
SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...
Samsung Biologics signs initial deal with LigaChem Bio on ADC production
Samsung Biologics Co., the world’s largest contract drugmaker, said on Thursday it has signed an initial agreement with LigaChem Biosciences I...
Celltrion BioSolutions launched to venture into CDMO
Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDM...
Boryung, Lotus Pharma signs CDMO deal on anticancer injection
South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...
HD Hyundai Oilbank supplies bio VLSFO to Yangming
HD Hyundai Oilbank Co., a South Korean crude oil refiner backed by Saudi Aramco, said on Thursday it started to supply Taiwan-based Yang Ming Marine...
SK Pharmteco bags obesity treatment deal worth up to $1.4 bn
SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...
Blackstone, Carlyle, MBK vying for CJ CheilJedang’s bio business
Blackstone, Carlyle Group and MBK Partners have joined the race to purchase the bio business of CJ CheilJedang Corp., the world’s largest prod...
Latvian President Rinkēvičs seeks closer ties with S.Korea in bio, defense
Latvian President Edgars Rinkēvičs, who is on a four-day working trip to South Korea, said on Friday he hopes for deeper cooperation between the two...
Celltrion to break ground on CDMO plant in 2025: Chairman Seo
South Korea’s leading biosimilar developer Celltrion Inc. will break ground on its first contract development and manufacturing organization (...
Samsung Biologics wins $668 million CDMO deal with European pharma
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...
CJ CheilJedang puts bio business on market for $4 bn
CJ CheilJedang Corp., South Korea’s largest food company, is seeking to sell its bio business for about 6 trillion won ($4.3 billion) in what ...
Celltrion to establish CDMO subsidiary
Celltrion Inc., South Korea’s largest biosimilar maker, said on Friday it plans to establish a contract development and manufacturing organiza...
LG Chem targets functional cosmetics market with bio-materials
LG Chem Ltd., the world’s fourth-largest chemicals manufacturer, is targeting the functional cosmetics market with bio-materials derived from ...
Celltrion earmarks billions of dollars to build CDMO plant: chairman
Celltrion Inc., South Korea’s largest biosimilar maker, will spend several billion dollars to build a factory to crack the contract developmen...
Celltrion chairman announces venture into CDMO market
South Korea’s biosimilar maker Celltrion Inc. will venture into the contract development and manufacturing organization (CDMO) market, the com...
Lotte to restructure bio business to focus on CDMO
South Korea’s retail-to-chemical conglomerate Lotte Group will restructure its bio business to focus on the profit-making medicine bio develop...
Korea's investment forum KIW 2024 kicks off September 9
South Korea’s largest investment forum Korea Investment Week 2024 (KIW 2024) will kick off next month in Seoul, drawing around 150 leaders fro...
Biotech stocks, foreigners’ top pick in Korea amid panic selling
Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...
HD Hyundai Oilbank exports bio marine fuel blends
The Korea Customs Service announced on July 29 that domestic petroleum products were exported after being blended in a bonded zone for the first tim...
LG to foster smart factory business as new B2B growth driver
PYEONGTAEK, Gyeonggi Province -- LG Electronics Inc., the leading global home appliance maker, aims to foster its smart factory business as a new gr...
Samsung Elec invests in US bio startup Element Biosciences
Samsung Electronics Co., the world’s top memory chipmaker, said on Friday it has invested in US biotech startup Element Biosciences Inc. to ex...
Samsung to invest $52 mn in US biotech VC Flagship Pioneering
Samsung C&T Corp., its bio units Samsung Biologics Co. and Samsung Bioepis Co. and Samsung Venture Investment Corp. have committed a combined 72...
Kwangdong Pharma acquires stake in Precision Bio
South Korea's Kwangdong Pharmaceutical announced on Tuesday that it signed a stock purchase agreement to acquire Precision Biosensor Inc., a company...
Lotte Biologics targets $1.1 billion in sales with new bio plants
South Korean biopharmaceutical company Lotte Biologics Co. said on Wednesday it is aiming for 1.5 trillion won ($1.1 billion) in annual sales by 203...
